RFP of the Day: Alzheimer's Drug Discovery Foundation invites LOIs for Neuroimaging and CSF Biomarker Program; grants of up to $600,000 will be awarded in support of research with the potential to develop and validate biomarkers for which there is a clear clinical need bit.ly/3U5YP3d

We're in a modern era #Alzheimers research bringing new hope to patients. In Scientific American, Bill Gates shares how his partnership with the #DiagnosticsAccelerator , which has catalyzed $60M into 58 biomarker programs, is paving the way for a more timely diagnosis
bit.ly/3xNaYSV

Innovative researchers wanted! The ADDF-Harrington Scholar Award offers funding, project management support, and regulatory assistance for breakthrough discoveries targeting #Alzheimers disease and related dementias. Alzheimer's Drug Discovery Foundation bit.ly/3PRv9E1

The #Alzheimers diagnostics landscape is rapidly evolving, and our CSO Howard Fillit, MD connected with C&EN (Chemical & Engineering News) to discuss the DxA, its funding of blood-based #biomarkers & #digital #diagnostic tools, and predictions for the future of #BloodTests . Read more here: bit.ly/3JaGZXR

Thank you Washington Capitals fans for helping us celebrate TJ Oshie by raising $41,582 for Alzheimer's Drug Discovery Foundation through our #TJ1K Auction. Proceeds will be used to help rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer's disease.

Reminder that our Washington Capitals #TJ1K Auction closes at 3 p.m. TODAY! Get your bids and donations in before it's too late. Proceeds benefit T.J.'s charity of choice, Alzheimer's Drug Discovery Foundation and will be used to help rapidly accelerate the development of drugs to prevent, treat and cure Alzheimer's

Calling all researchers! Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines invite proposals for the 2024 ADDF-Harrington Scholar Award. Propel your Alzheimer's research forward! Learn more bit.ly/3PRv9E1 #ADDF #HarringtonScholar

Recent studies show that up to 40% of patients with #Alzheimers also have alpha-synuclein deposits, suggesting this is a promising pathway to develop #novel drugs & biomarkers for. The Wall Street Journal features ADDF-funded Amprion's alpha-synuclein #biomarker here: on.wsj.com/3TPuE18

Fascinating chat, hosted by Alzheimer's Drug Discovery Foundation, with 2 notable names in the #Alzheimers research field: Phyllis Ferrell & Dr Laura Nisenbaum. They discuss the current state of AD research, biomarkers, & reasons for hope. 🙌🔬🧠
bit.ly/4ctb6ak
#dementia

In the wake of the FDA's decision to hold an Advisory Committee to learn more about #donanemab 's unique trial design, our CSO, Howard Fillit, MD, connected with PharmaVoice on what this means for the #Alzheimers space & recent breakthroughs in #DrugDevelopment : bit.ly/43n2JJj

One of the many unique aspects of #donanemab 's trial is that patients stopped receiving the drug once PET scans showed that the drug had cleared #amyloid . Our CSO, Howard Fillit, MD, discusses the economic & clinical benefits of these stopping rules with Endpoints News: bit.ly/4a3Aqly

The #FDA decision to hold an Advisory Committee for #donanemab is likely due in part to the #AntiAmyloid drug's unique trial design. Our CSO, Howard Fillit, MD, discusses the #biomarker -powered trial that used #tau staging and stopping rules in BioSpace: bit.ly/4acT0HE

After decades of clinical trial learnings, we've entered a new era of #Alzheimers research with several drug & #biomarker breakthroughs. Our CSO, Howard Fillit, MD, connected with AARP to discuss the #BiologyOfAging , #CombinationTherapy & #PrecisionMedicine : bit.ly/3x3vyOI

Congratulations to friend of the ADDF TJ Oshie on his 1,000th career #NHL game! To celebrate the milestone, he and his fellow Washington Capitals teammates plan to sign & auction their warmup jerseys to benefit the ADDF. Details on the fundraiser here: bit.ly/3PRYrUP MSE Foundation

The Capitals will honor T.J. Oshie for reaching 1,000 career games on Sunday, March 24, when the Capitals host the Winnipeg Jets at Capital One Arena at 12:30 PM.

During the ceremony, TJ Oshie will receive a special gift from the NHL, the organization and his teammates.

#TJ1K

In honor of Washington Capitals TJ Oshie's 1,000th NHL game milestone, Capitals players will wear #77 jerseys during warmups on March 24. The jerseys will be signed and auctioned off in a MSE Foundation TJ1K Jersey Auction to benefit Alzheimer's Drug Discovery Foundation, whose mission is to rapidly accelerate the

📣 Sending our appreciation to our 2024 GAP-Net Site Optimization Conference SILVER sponsors, AbbVie Acadia Pharmaceuticals Alzheimer's Drug Discovery Foundation Bluefield Project Eisai US IQVIA Linus Health Roche RetiSpec, for your support for the GAP-Net Conference in NOLA. #Thankyou #GAPNet2024

Our 2024 Annual Research Meeting gave us a sense of gratitude & anticipation for what's ahead. Your participation has been instrumental in this journey & we're excited to keep moving forward with you. Check out our video here ckmeeting.org #Alzheimer #dementia

Today, Eli Lilly announced the #FDA plans to convene an Advisory Board to further review the efficacy & safety profile of #donanemab . Though unexpected, this is not a setback—it's the same regulatory process used for #Leqembi . Read our statement here: bit.ly/3T7xz3U

Today #ADDF Co-Founder and Chief Science Officer Howard Fillit, MD delivered a poignant plenary lecture at #ADPD2024 on why the biology of aging framework will guide the next generation of #Alzheimers drugs as we move towards combination therapy and #precisionmedicine . AD/PD - Advances in Science & Therapy